Export Ready — 

Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy

Objectives. To evaluate the efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus (SLE) and lupus nephritis (LN) who are refractory to conventional immunosuppressive therapy. Methods. Eligible patients received rituximab at a dose of 1,000 mg at days 1, 15, 169, and...

Full description

Saved in:
Bibliographic Details
Published in:Mod Rheumatol
Main Authors: Tanaka, Yoshiya, Takeuchi, Tsutomu, Miyasaka, Nobuyuki, Sumida, Takayuki, Mimori, Tsuneyo, Koike, Takao, Endo, Kazuhiro, Mashino, Naomi, Yamamoto, Kazuhiko
Format: Artigo
Language:Inglês
Published: Taylor & Francis 2016
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4732415/
https://ncbi.nlm.nih.gov/pubmed/26054418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/14397595.2015.1060665
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items